Long-term outcome of patients with asystole induced by head-up tilt test
|
|
- Imogen Cameron
- 6 years ago
- Views:
Transcription
1 European Heart Journal (2002) 23, doi: /euhj , available online at on Long-term outcome of patients with asystole induced by head-up tilt test G. Barón-Esquivias 1, A. Pedrote 1, A. Cayuela 2, J. I. Valle 1, J. M. Fernández 1, E. Arana 1, M. Fernández 1, F. Morales 3, J. Burgos 1 and A. Martínez-Rubio 4 1 Cardiology Department and 2 Supportive Unit for Research, Hospital Universitario Virgen del Rocío, Sevilla; 3 Cardiology Section, Hospital de Puerto Real, Cadiz, 4 Cardiology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain Aims To analyse the long-term outcome of the largest reported cohort of patients presenting asystole during head-up tilt test. Methods and Results Since 1990, 1322 patients with syncope of unknown origin have undergone tilt-table testing. Of those, 330 patients (24 9%) presented an abnormal response (syncope or pre-syncope). Furthermore, 58 of those patients (17 5%) suffered a period of asystole ( 3000 ms) during the test. Asystole (median (interquartile range)) lasted 10 (4, 19 2) s (range 3 90). Two different protocols (angles) of tilting (Westminster (60 ) n=1124; isoproterenol (80 ) n=198)) influenced the time to the syncopal episode (13 (6 5, 20 5) vs 2 (1, 6 5) min, P=0,0005) but not the duration of the asystole. During this period, therapy for asystole featured three different stages: first patients were treated with pacemakers; later drug therapy (metoprolol and/or etilefrine) was recommended; lastly (from 1995), no specific treatment was given. In a cohort age- and gender-matched study, those patients without were compared to those with asystole in a 2:1 basis. During 40 7 months of follow-up (17 7, 66 8), 12 patients (20 6%) with asystole had syncopal recurrences. Furthermore, 34 patients (28 8%) without asystole presented syncopal episodes during a follow-up of 51 6 months (29 3, 73 1) (P=ns). The Kaplan Meier analysis in patients with and without asystole showed a mean time free of recurrence of months vs months (P=ns). The previous number of syncopes had a significant relationship with recurrences (P=0 002), but not therapy. There were no cardiac related deaths. Conclusions (1) Asystole during head-up tilt test does not imply a malignant outcome and syncope recurrence is low; (2) pacemaker or drug therapy do not significantly influence outcome which correlates to the previous number of syncopal episodes but not to gender, age, asystole occurrence, asystole duration and timing to asystole during head-up tilt test; (3) tilting protocol (angle) might influence time to and incidence of asystole during head-up tilt test. (Eur Heart J 2002; 23: , doi: /euhj ) 2001 The European Society of Cardiology Key Words: Asystole, treatment, syncope, tilt-test. See page 433, doi: /euhj for the Editorial comment on this article Introduction Since Kenny et al. [1] suggested use of the tilt-table test as a screening strategy for neurocardiogenic syncope, various physiopathological responses [2,3] have been observed. At present, neurocardiogenic syncope is generally considered to be a benign condition [4], although some authors have related it to rare events of sudden death [5]. Among patients developing bradycardia during Revision submitted 1 May 2001, accepted 2 June 2001, and published online 21 November Correspondence: Gonzalo Barón-Esquivias, MD, Avda de Portugal, izda, Sevilla, Spain. gbaron@jet.es X/02/ $35.00/0 the head-up tilt test, there is a subgroup in whom an asystole occurs (Fig. 1) and on rare occasion has even required measures of cardiopulmonary resuscitation [6 8]. Few data on prognosis of those patients with asystole during head-up tilt test exist [9 12]. Therefore, the aim of this paper is to present the long-term outcome of the largest cohort of such patients. Methods Patients From September 1990 to May 2000, 1322 patients with syncope of unknown origin were referred for head-up 2001 The European Society of Cardiology
2 484 G. Barón-Esquivias et al. FC 50 DERIV. II FC 38 DERIV. II FC 0 DERIV. II FC 100 Figure 1 Continuous ECG of a patient from Group A during head-up tilt test showing an asystole of ms. The patient had no recurrences during 78 7 months of follow-up. tilt test at the Cardiology Department of Virgen del Rocío General Hospital (Sevilla, Spain). All patients had suffered: (a) 2 syncopal episodes, (b) 1 syncopal and 2 pre-syncopal episodes, or (c) a single episode of syncope causing injury or hospital admission. All patients had normal ECG, echocardiogram, exercise test and Holter monitoring. After informed consent was obtained, all patients underwent head-up tilt test off drugs. From those 1322 patients, an abnormal test response (syncope or pre-syncope with vasodepressor, cardioinhibitory and mixed responses) was observed in 330 patients (24 9%), and 58 of those 330 patients (17 5%) suffered an asystole (pause 3000 ms) during head-up tilt test and form the cohort of the study (group A). In order to compare the influence of the asystolic response during head-up tilt test on prognosis, a control group (group B) was composed of patients with a vasovagal response during head-up tilt test but without asystole. These patients were chosen at random, but on an age- and gender-matched 2:1 basis, bearing in mind the head-up tilt test protocol and time periods in which the various treatment strategies tended to be favoured (e.g. there would be 12 controls for the first six pacemaker-treated patients, etc.). The clinical characteristics of both groups were comparable (Table 1). Head-up tilt-table test protocol All head-up tilt tests were performed between 0800h and 1400h with the patients fasting. After venipuncture and throughout the test, a saline solution was infused at a rate of 20 ml. h 1. Baseline heart rate and arterial pressure were measured after the patient had been in a supine position for 10 min. During the test, patients were monitored with a three-lead ECG and blood pressure was measured every 1-2 min with an automatic sphygmomanometer, or continuously, if symptoms appeared. The Westminster protocol [13], which consists in tilting the table up to 60 for 45 min with the patient s feet resting on a foothold, was used in 1124 patients. In addition, another 198 patients studied during 1994 underwent another head-up tilt test protocol with isoproterenol challenge, according to Almquist et al. [14] (briefly: tilt angle of 80 ; 20 min without any drug, later isoproterenol is infused from 2 to 5 μg. min 1 ). The time needed to change the tilt-table from 60 and 80 to a supine position was 12 and 15 s, respectively. Definitions Syncope was defined as sudden transient loss of consciousness, with inability to maintain postural tone, and with spontaneous recovery. Pre-syncope was defined as the complex of premonitory signs and symptoms of imminent syncope (e.g. severe light-headedness, severe weakness, transient graying of vision, or hearing loss) with difficulty in maintaining postural tone. A vasovagal or neurocardiogenic response to head-up tilt test was defined as reproduction of the spontaneous syncope or Table 1 Demographic characteristics of study (group A) and control (group B) populations. Thre was no significant difference between the groups Group A (n=58) Group B (n=118) Female (%) 24 (41%) 57 (48%) Age (year) 35 (19 5, 59 5) 29 (17, 51) Number of syncopes 3 (1, 5) 3 (1, 8) Evolution time (months) 24 (6, 60) 36 (3, 118) Follow-up time (months) 40 7 (17 7, 66 8) 51 6 (29 3, 73 1) Data are expressed as median (interquartile range).
3 Long-term outcome of patients with asystole induced by head-up tilt test 485 pre-syncope in association with hypotension, bradycardia, or both (decrease in systolic blood pressure >50% and decrease in heart rate >30% of the maximal value observed in the upright position). Asystole was defined as an interruption in ventricular activity (during a cardioinhibitory or mixed response to head-up tilt test), lasting for 3000 ms or more based on the definitions of the VASIS study [3] and ACC recommendations for pacing in bradyarrhythmias [15]. Therapeutic strategies and follow-up The decision on how and who to treat was not based on the number of previous syncopes, but on our own chronological experience. From September 1990 to November 1992, permanent DDD-pacing was recommended to all patients with asystole (n=6) but one patient refused this treatment. From November 1992 to June 1995, drug therapy (metoprolol 50 mg. 12 h 1 ; etilefrine 10 mg.8h 1 ) or implanting a pacemaker, if drug therapy failed to prevent recurrences of syncope, was recommended to those (n=21) patients with asystole during head-up tilt test. At the time of writing, only nine of those patients are persisting with pharmacological treatment. Among these nine patients, one pacemaker has been implanted. After June 1995, patients (n=31) received no specific treatment. However, if recurrence occurred, then drug or pacemaker therapy was considered. As previously mentioned, group A and B patients were randomly matched on gender, age and treatment period. In group B, 11 first period patients had no treatment, and one received a pacemaker. Forty-two patients of the second period received pharmacological treatment. At the time of writing, only 14 patients are still being administered this therapy. Among these 14 patients, one pacemaker has also been implanted. In 64 patients of the third period, two are empirically treated, and one received a pacemaker. All patients of both groups received advice, increased their salt intake, and were informed about how to avoid the classic situations which facilitate syncope. They were also informed on how to recognize syncope prodromes and were urged to sit down or lie down quickly. After discharge, follow-up at our outpatient clinic or by phone was carried out every 6 12 months. Statistical analysis In order to compare the influence of the asystolic response during head-up tilt test on prognosis, a cohort study was designed. Continuous variables were expressed as median (interquartile range) when their distribution is not normal, and as mean SD when their distribution is normal. These variables were compared by Mann Whitney or Student t-test. The Fisher or chi-square test was used for comparison of qualitative variables. The cumulative risk of syncope over time was estimated using the Kaplan Meier procedure, and Kruskal Wallis test was used for correlation between treatment and time to recurrence. A two-tailed P value <0 05 was considered significant. Data were analysed with version 10 of SPSS software (SPSS, Chicago, Illinois). Results Asystole occurred in 45 of 1124 patients (4%) and in 13 of 198 patients (6 5%) using a Westminster and isoproterenol protocol (tilting angle of 60 and 80 ) (P<0 04), respectively. There were no differences in age [29 (17 5, 49) vs 30 (16, 52) years], gender (female: 40% vs 46%), number of previous syncopes [4 (2, 12) vs 3 (1 5, 8 5)] or duration of symptoms [42 (4 5, 129) vs 36 (6, 114) months] between patients with asystole included in both tilting protocols. Overall, the asystole lasted for a median of 10 (4, 19 2) s (range 3 90). This event occurred after 13 (6 5, 20 5) min and lasted for a median of 10 (4, 20) s (range 3 90) using the Westminster (tilting angle of 60 ) protocol. However, using the isoproterenol protocol (tilting angle of 80 ), the asystole occurred after 2 (1, 6 5) min of isoproterenol infusion (P= compared to Westminster protocol) and its mean duration was 13 (5, 17) s (range 3 36) (P=ns compared to Westminster protocol). Follow-up was obtained from all patients. There were no cardiac-related deaths (mean follow-up 43 4 months (18 1, 67 5). One patient in group A (71 years old) and two patients in group B (87 and 73 years old) died from causes unrelated to heart disease (cancer n=2, septicaemia n=1) during follow-up. Follow-up durations in groups A and B patients were 40 7 months (17 7, 66 8) and 51 6 months (29 3, 73 1) (P=ns), respectively. Twelve patients (20 6%) in group A and 34 (28 8%) in group B had recurrences (P=ns). In group A, 10 patients had one syncopal recurrence, and two patients had two or more. In group B, 24 patients had one syncopal recurrence, and 10 had two or more. Compared to patients free of recurrences, those patients with recurrences suffered more syncopes before head-up tilt test (4 5 (3, 12) vs 3 (1, 5); P=0 002, respectively) but there were no differences in gender, age, asystolic pause occurrence or duration, timing to asystole during head-up tilt test or follow-up duration. Seven patients of group A and 15 of group B had only one syncope before undergoing head-up tilt test. During follow-up, no difference was noted compared with other patients of both groups. The occurrence of new syncopal events during follow-up was not dependent on the presence of asystole, or the chosen therapy. In the first therapeutic approach, 2/8 patients (25%) treated with pacemakers, 18/62 patients (29%) treated with drug therapy and 26/106 patients (25%) who received only advice, suffered recurrences. The Kaplan Meier analysis (Fig. 2) shows a
4 486 G. Barón-Esquivias et al. 1 0 Kaplan-Meier analysis of recurrence % syncope-free Time (months) Figure 2 Kaplan Meier estimates of recurrence in 58 patients with asystole ( ) (group A) and in 118 patients without an asystolic response ( ) during head-up tilt test (group B). mean time free of recurrence of months vs months respectively, in groups A and B (P=ns), and a cumulative probability of no recurrence of 70 7% vs 66 7% (P=ns) during the follow-up. Discussion This study provides four main results. First, although asystole during head-up tilt test occasionally causes considerable concern, no cardiac deaths were observed, and consequently such finding does not imply a malignant outcome. Second, the presence of asystole during head-up tilt test does not signify a tendency to syncope recurrence. In addition, most of the patients with recurrences had just one new syncopal episode. Third, pacemaker or drug therapy does not significantly influence outcome. Outcome seems to correlate to the previous number of syncopal episodes but not to gender, age, asystole occurrence, asystole duration, timing to asystole during head-up tilt test, or follow-up duration. Finally, tilting protocol (angle) may influence the time until and incidence of asystole during head-up tilt test. Prevalence and duration of asystole Previous reports have documented the occurrence of prolonged asystole during head-up tilt test. In 1989 Fitzpatrick and Sutton [16] described a 10% incidence of asystole usually with hypotension. At a later date [17], the same authors published a study on 37 patients who underwent pacemaker implantation. This collective report included 11 patients with asystole lasting longer than 4000 ms. From those 11 patients, eight suffered recurrences. In accordance to our observations, these data do not suggest a beneficial outcome from pacing treatment. Later, Sra et al. [18] reported six asystolic events (8 5%) in a group of 70 patients with an abnormal head-up tilt test. In addition, Dhala et al. [9] found that from 209 consecutive patients with a history of syncope and abnormal head-up tilt test, 19 patients (9%) presented an asystole lasting 5000 ms. Furthermore, Grubb et al. [19] described an asystolic response (>4000 ms) in 10 (20%) of 50 patients with recurrent syncope, whereas Brignole et al. [20] reported on 28 patients (18%) with asystole ( 3000 ms) among 152 consecutive patients. Deal et al. [21] described a lower (4 5%) incidence of asystole ( 5000 ms) among 398 consecutive paediatric patients. In Spain, Pérez-Paredes et al. [22] published their experience with a cohort of 12 patients with asystole. However, they do not specify the prevalence of asystole in relation to the population studied. Our study is the largest (n=58) cohort of patients with asystolic events out of a total of 1322 consecutive patients (4 3%) in whom head-up tilt test was performed. If we had defined asystole using a cut-off point of 4000 or 5000 ms, then this event would have been considered to occur in 48 and 43 patients, respectively. Interestingly, the main findings of the study in relation to follow-up did not change. The occurrence of prolonged pauses on head-up tilt test, do not correlate with the clinical presentation of initial symptoms, or with a worst prognosis during follow-up. From our data, the proportion of ventricular asystole is significantly greater during isoproterenol (tilting angle of 80 ) than during the Westminster protocol (tilting angle of 60 ): 6 5% vs
5 Long-term outcome of patients with asystole induced by head-up tilt test 487 4%; P<0 04. It is well known that isoproterenol, a beta 2 stimulant, increases heart rate and, as a such, it would be expected to reduce the rate of the occurrence of the cardioinhibitory response and of ventricular asystole during head-up tilt test, as previously reported by Brignole et al. [20]. However, our data do not confirm these expectations as our responses were similarly variable (mixed, cardioinhibitory and vasodepressor responses) comparing both protocols [23]. Furthermore, our data suggest that the angle of tilting and the necessary time to change to the Trendelenburg position might be implicated in the incidence of the asystole. Our findings and data of other authors [5,6,15 19] indicate that the return to the supine position after syncope development is usually enough to allow recovery of spontaneous sinus rhythm, normalization of blood pressure and termination of the event. There is a lack of data on the relationship between changing the tilt-table to the supine or Trendelenburg position and duration of asystolic events. In our case, it takes 12 and 15 s to tilt the table from a 60 - and 80 -angle to Trendelenburg ( 20 ), respectively. If an asystole occurs, it usually does so at an early stage of the head-up tilt test and is almost always accompanied by syncope, which usually lasts until Trendelenburg conditions have been achieved or longer. Thus, lowering of the tilt-table should be done as fast as possible. In this context, the ACC Expert Committee [24] recommend that lowering the tilt-table from an angle of 60 to the Trendelenburg position should not exceed s. Although there are several reports on head-up tilt test, this aspect, which in our opinion is of paramount importance, is almost never reported. In our series, the duration of asystole did not significantly differ between either protocol (Westminster and isoproterenol). However, using isoproterenol (tilting angle of 80 ), asystole appeared at a significantly earlier stage. Follow-up and treatment of patients with asystole There is a broad range of reported syncope recurrences between patients with asystole during head-up tilt test, which obviously depends on patient selection and follow-up duration. For example, Dhala et al. [9] found that two of 19 patients (11%) with asystole suffered recurrences during a follow-up of years, whereas Pérez-Paredes et al. [22] reported that recurrences occurred in four of 12 (36%) patients with the same characteristics during a mean follow-up of months. In addition, Deal et al. [21] described an incidence of 22 2% among 18 paediatric patients under different therapeutic regimens during 31 months of follow-up. Furthermore, Brignole et al. [20] reported recurrences of syncope in five of 28 patients (18%) with asystolic responses and in 10 of 28 patients (36%) in the non-asystolic group during a follow-up of and months (P=ns). These findings are in accordance with ours, which show no better outcome in those patients without asystole. During 40 7 months (17 7, 66 8), only 12/58 of our patients (20 6%) with asystole suffered syncopal recurrences (one episode n=10; mean time free of recurrence of months; cumulative probability of no recurrence of 70 7%). When follow-up data were compared to those patients without asystole during head-up tilt test no differences could be observed. In our opinion, this recurrence rate, and especially the absence of any cardiac deaths, suggest that the appearance of asystole during the tilt-table test does not imply a malignant outcome. In our series only the number of previous syncopal events influenced the outcome. When treating patients with several previous syncopal episodes the aim must be to avoid even one episode over many years of follow-up. Menozzi et al. [12] implanted a specially designed pacemaker able to detect and store all asystolic episodes lasting 3 to 6 or >6 s in 23 patients. Only two of those patients had asystole during head-up tilt test. Interestingly, one of the two patients had several pauses (30 pauses of 3 to 6 s and three pauses >6 s) during follow-up, while the other had just one pause (3 to 6 s) and no syncopal recurrence. Treatment of vasovagal syncope is a matter of controversy [17,18,20 43]. Based on our findings since June 1995, we first recommend education in the form of advice, as described above, although patients and their physicians are informed in detail about the therapeutic options and our own experience about outcome. As recommended by Di Girolamo et al. [44], education may include a tilting training programme, but we do not use it. We only recommend drug or pacing treatment in those patients with neurocardiogenic syncope who have suffered recurrences after an abnormal head-up tilt test despite the type of pathological response during the tilt-test. The pharmacological approach to vasovagal syncope has been recently questioned in two double blind, randomized, placebo-controlled trials that show a similar efficacy for etilefrine and placebo [45], and atenolol and placebo [46]. Our own experience is in accordance with these data. Initially, the Westminster Hospital group [2,17] considered the appearance of bradycardia and asystole during the head-up tilt test sufficient for implanting a pacemaker. These patients were thought to have a worrisome outcome. At first we also used that approach. Now we have come to the conclusion that there is no definitive therapy since untreated patients in our study present a similar outcome to patients receiving pacemaker or drug therapy. In addition, two recent randomized trials of permanent cardiac pacing for the prevention of vasovagal syncope have been published [47,48]. The first of these studies focused on the number of previous syncopes, but not on asystole duration. The authors conclude that it would be reasonable to consider implanting a pacemaker in highly symptomatic patients with frequent vasovagal syncope who also have a relative bradycardia on tilt-table testing. However, syncope recurrences occurred in 19 of 27 patients without and also in 6 of 27
6 488 G. Barón-Esquivias et al. patients treated with pacemakers [47]. Recently, Sutton et al. [48] reported the results of a multicentre randomized trial. They conclude that in a limited selected group of patients with a cardioinhibitory response during tilt-test, DDI pacing with hysteresis reduced the likelihood of syncope with maintenance of benefit over time. Several differences exist between this and our study. The main one is that we present a consecutive and larger cohort of patients, whereas these authors report on a highly selected collective of 42 patients included over a period longer than 6 years from 18 participating centres. As the authors recognize, it is likely that only the worst or more severe cases were included. Interestingly, pacemaker therapy was not superior to no therapy in preventing tilt-induced syncope during repeat tilt testing performed within 15 days of enrolment [48], as also indicated by previous authors [18]. This short-term outcome may not necessarily be identical to spontaneous long-term outcome. However, it makes it difficult to understand the mechanisms of syncope and the preventive mechanisms of pacemakers in this context. Studies that are not blinded (e.g. pacemaker implantation) [47,48] cannot exclude a bias in assessment of outcome and a psychological benefit ( placebo effect ) of pacemaker therapy. The reason for the decrease in syncope recurrence rate after diagnostic procedures, even in untreated patients, might indicate that syncopes occur in clusters or that patients learn to recognize prodromes and how to avoid the events, which is what our patients were systematically taught to do. Our data indicate a relationship between recurrences and the number of previous syncopes but not the chosen therapy. Thus, in agreement with other authors [3,13,18,21,27,28] and considering our large cohort of patients (with a mean time free of recurrence of 92 6 months and without any cardiac death), we do not believe that pacemakers should be considered routinely as first choice therapy. This is substantiated by the fact that we and other authors (e.g. [48] ) document a benign outcome unrelated to therapy. However, the recurrence rate of syncope (with any strategy) indicates the need for better identification of those individuals who might benefit from specific therapeutical approaches. This aim will probably only be achieved after better understanding the pathophysiological mechanisms of syncope and identification of specific subgroups of patients. Limitations Treatment of patients was not randomized but chronologically (10 years) adapted based on experience. Thus, first the theoretically safest approach (pacemaker) was undertaken for ethical reasons. However, the experience suggests that the initial treatment is not necessarily the best. During follow-up, the occurrence of pre-syncope is not evaluated because an accurate and objective evaluation would not be possible. Conclusions (1) Asystole during head-up tilt test does not imply a malignant outcome although recurrences occur; (2) pacemaker or drug therapy do not significantly influence outcome which correlates to the previous number of syncopal episodes but not to gender, age, asystole occurrence, asystole duration and timing to asystole during head-up tilt test; (3) tilting protocol (angle) might influence time to and incidence of asystole during head-up tilt test. We specially thank David G. Benditt, MD and Juan Cinca Cuscullola, MD for their critical review and comments. References [1] Kenny RA, Ingram A, Bayliss J, Sutton R. Head-up tilt a useful test for investigating unexplained syncope. Lancet 1986; 1: [2] Fitzpatrick A, Theodorakis G, Vardas P et al. The incidence of malignant vasovagal syndrome in patients with recurrent syncope. Eur Heart J 1991; 12: [3] Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P. Proposed classification for tilt induced vasovagal syncope. Eur J Card Pacing Electrophysiol 1992; 3: [4] Benditt DG. Neurally mediated syncopal syndromes: Pathophysiological concepts and clinical evaluation. PACE 1997; 20: [5] Milstein S, Buetinofer J, Lesser J et al. Cardiac asystole: a manifestation of neurally mediated hypotension-bradycardia. J Am Coll Cardiol 1989; 14: [6] Maloney J, Jaeger F, Fouad-Tarazi F, Morris H. Malignant vasovagal syndrome: prolonged asystole provoked by head up tilt. Cleve Clin J Med 1988; 55: [7] Pedrote A, Errazquin J, Quero J, Sobrino M, Hernández MC. Prolonged cardiac asystole that requires resuscitation manoeuvers during a Head-up tilt table test. Rev Esp Cardiol 1993; 46: [8] Barón-Esquivias G, Pedrote-Martínez A, Errázquin-Saez de Tejada F. Anomalous result and worsening of vasovagal syncope after a therapeutic regime with metoprolol guided by head-up tilt test. Eur J Card Pacing Electrophysiol 1996; 6: [9] Dhala A, Natale A, Sra J et al. Relevance of asystole during Head-up tilt testing. Am J Cardiol 1995; 75: [10] Folino AF, Buja GF, Martini B, Miorelli M, Nava A. Prolonged cardiac arrest and complete AV block during upright tilt test in young patients with syncope of unknown origin-prognostic and therapeutic implications. Eur Heart J 1992; 13: [11] Barón G, Pedrote A, Cardenal R, Pérez Cano B, L-Haldón J, Errazquin F. Estudio y tratamiento de la asistolia desarrollada durante el test de la tabla basculante (Abstr). Rev Esp Cardiol 1998; 51 (Suppl 5): 65. [12] Menozzi C, Brignole M, Lolli G et al. Follow-up of asystolic episodes in patients with cardioinhibitory, neurally mediated syncope and VVI pacemaker. Am J Cardiol 1995; 72: [13] Fitzpatrick AP, Theodorakis G, Vardas P, Sutton R. Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 1991; 17: [14] Almquist A, Goldberg IF, Milstein S, Chen MY, Chen XC, Hansen R. Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Engl J Med 1989; 320: [15] Gregoratos G, Ceitlin MD, Conill A et al. ACC/AHA Guidelines for implantation of cardiac pacemakers and
7 Long-term outcome of patients with asystole induced by head-up tilt test 489 antiarrhythmia devices: Executive summary. Circulation 1998; 97: [16] Fitzpatrick A, Sutton R. Tilting towards a diagnosis in unexplained recurrent syncope. Lancet 1989; 1: [17] Petersen ME, Chamberlain-Webber R, Fitzpatrick AP, Ingram A, Williams T, Sutton R. Permanent pacing for cardioinhibitory malignant vasovagal syndrome. Br Heart J 1994; 71: [18] Sra JB, Jazayeri MR, Avitall B et al. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med 1993; 328: [19] Grubb BP, Temesy-Armos P, Moore J, Wolfe D, Hahn H, Elliot L. Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome. Am J Cardiol 1992; 69: [20] Brignole M, Menozzi C, Gianfranchi L, Bottoni N, Lolli G. The clinical and prognostic significance of the asystolic response during the head-up tilt test. Eur J Cardiovasc Pacing Electrophysiol 1992; 2: [21] Deal BJ, Strieper M, Scagliotti D et al. The medical therapy of cardioinhibitory syncope in pediatric patients. PACE 1997; 20: [22] Pérez-Paredes M, Picó F, Sánchez JG et al. Prognosis and long-term follow-up in patients with syncope of unknown origin and cardiac asystole induced by head-up tilt test. Rev Esp Cardiol 1997; 50: [23] Barón-Esquivias G, Pedrote A, Cayuela A et al. Age and gender differences in basal and isoprenaline protocols for head-up tilt table testing. Europace 2001; 3: [24] Benditt DG, Ferguson DW, Grubb BP et al. Tilt table testing for assessing syncope. American College of cardiology. J Am Coll Cardiol 1996; 28: [25] Petersen ME, Price D, Williams T, Jensen N, Rift K, Sutton R. Short AV interval VDD pacing does not prevent tilt induced vasovagal syncope in patients with cardioinhibitory vasovagal syndrome. PACE 1994; 17: [26] el-bedawi JCM, Wahbha MA, Hainsworth R. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope. Clin Auton Res 1994; 4: [27] Benditt DG. Cardiac pacing for prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: [28] Benditt DG, Petersen M, Lurie KG, Grubb BP, Sutton R. Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Intern Med 1995; 122: [29] Sheldon R. Pacing to prevent vasovagal syncope. Cardiol Clin 2000; 18: [30] Sra JS, Jazayeri MR, Dhala A, Deshpande S, Blanck Z, Akhtar M. Neurocardiogenic syncope, diagnosis, mechanisms, and treatment. Cardiol Clin 1993; 11: [31] Fitzpatrick A, Theodorakis G, Ahmed R, Williams T, Sutton R. Dual chamber pacing aborts vasovagal syncope induced by head-up 60: tilt. PACE 1991; 14: [32] Moya A, Permanyer G, Sagrista J, Mont L, Rius T, Soler J. Response to dual chamber pacing patients with syncope and positive tilt test with cardioinhibitory response (Abstr). PACE 1993; 16: 936. [33] Samoil D, Grubb BP, Brewster P. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope. Eur J Cardiovasc Pacing Electrophysiol 1993; 1: [34] Maloney JD, Jaeger FJ, Rizo-Patron C, Zhu DW. The role of pacing for the management of neurally mediated syncope: Carotid sinus syndrome and vasovagal syncope. Am Heart J 1994; 127: [35] Kosinski D, Grubb BP, Elliot L, Dubois B. Treatment of malignant neurocardiogenic syncope with dual chamber cardiac pacing and fluoxetine hydrochloride. PACE 1995; 18: [36] Lacroix D, Koukam C, Plug D et al. Asystolic cardiac arrest during head-up tilt test: incidence and therapeutic Implications. PACE 1997; 20: [37] Benditt DG, Sutton R, Gamage M and the rate-drop response investigators: Clinical experience with Thera-DR rate drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. PACE 1997; 20: [38] Grubb BP. Permanent cardiac pacing: New and emerging indications other than cardiomyopathies. In: Barold S, Mugica J, ed. Recent advances in cardiac pacing: Goals for the 21st Century, Vol 4. Armonk, NY: Futura Publishing Co., 1998: [39] Sheldon R, Koshman ML, Wilson W, Kieser T, Rose S. Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally mediated syncope. Am J Cardiol 1998; 81: [40] Abe H, Iwami Y, Nagatomo T, Miura Y, Nakashima Y. Treatment of malignant neurocardiogenic vasovagal syncope with a rate drop algorithm in dual chamber cardiac pacing. PACE 1998; 21: [41] McLeod KA, Wilson N, Hewitt J, Norrie J, Stephenson JBP. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart 1999; 82: [42] Shah CP, Thakur RJ, Xie B, Pathak P. Dual chamber pacing for neurally mediated syncope with a prominent cardioinhibitory component. PACE 1999; 22: [43] Mitton CR, Rose MS, Koshman ML, Sheldon RS. Costutility analysis of pacemakers for the treatment of vasovagal syncope. Am J Cardiol 1999; 84: [44] Di Girolamo E, Di-Torio C, Leonzio L et al. Usefulness of a tilt training program for the prevention of refractory neurocardiogenic syncope in adolescents: a controlled study. Circulation 1999; 100: [45] Raviele A, Brignole M, Sutton R et al. Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope. A double-blind randomized placebo-controlled trial. Circulation 1999; 99: [46] Madrid AH, Ortega J, Rebollo JG et al. Lack of efficacy of atenolol for the prevention of neurally mediated syncope, in a highly symptomatic population. A prospective, double blind, randomized and placebo controlled study. J Am Coll Cardiol 2001; 37: [47] Connolly SJ, Sheldon R, Roberts RS, Gent M. The North American Vasovagal pacemaker study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: [48] Sutton R, Brignole M, Menozzi C et al., for the Vasovagal Syncope International Study (VASIS) Investigators. Dualchamber pacing in the treatment of neurally mediated tiltpositive cardioinhibitory syncope. Pacemaker versus no therapy: a multicenter randomized study. Circulation 2000; 102:
Incidence, Clinical Presentation. and Outcome in Patients with Long. Asystole Induced by Head-up Tilt Test
2005 16 134-138 Incidence, Clinical Presentation and Outcome in Patients with Long Asystole Induced by Head-up Tilt Test Ming-Ting Chou, Chen-Chuan Cheng, Wen-Shiann Wu, and Tseui-Yuen Huang Division of
More informationProlonged Asystole during Head-Up Tilt Test in a Patient with Malignant Neurocardiogenic Syncope
Case Report Prolonged Asystole during Head-Up Tilt Test in a Patient with Malignant Neurocardiogenic Syncope Takashi Tokano MD 1, Yuji Nakazato MD 2, Akitoshi Sasaki MD 3, Gaku Sekita MD 3, Masayuki Yasuda
More informationOriginal Article Usefulness of Tilt Testing in Children with Syncope: A Survey of Pediatric Electrophysiologists
www.ipej.org 242 Original Article Usefulness of Tilt Testing in Children with Syncope: A Survey of Pediatric Electrophysiologists Anjan S. Batra, MD 1 and Seshadri Balaji, MBBS, MRCP (UK), PhD 2. 1 University
More informationEfficacy of tilt training in the treatment of neurally mediated syncope. A randomized study
Europace (2004) 6, 199e204 Efficacy of tilt training in the treatment of neurally mediated syncope. A randomized study Giovanni Foglia-Manzillo a, ), Franco Giada b, Germano Gaggioli c, Angelo Bartoletti
More informationThe usefulness of cardiac pacing for prevention of syncopal
Dual-Chamber Pacing in the Treatment of Neurally Mediated Tilt-Positive Cardioinhibitory Syncope Pacemaker Versus No Therapy: A Multicenter Randomized Study Richard Sutton, DSc Med; Michele Brignole, MD;
More informationCardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures
Heart 1999;82:721 725 721 Department of Cardiology, Royal Hospital for Sick Children, Yorkhill NHS Trust, Glasgow G3 8SJ, UK K A McLeod N Wilson J Hewitt Department of Neurology, Royal Hospital for Sick
More informationUtility of a Single-Stage Isoproterenol Tilt Table Test in Adults A Randomized Comparison With Passive Head-Up Tilt
Journal of the American College of Cardiology Vol. 33, No. 4, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(98)00658-5 Utility
More informationJACC Vol. 25, No January 1995:65-9
JACC Vol. 25, No. 1 65 Limitations of Head-Up Tilt Test for Evaluating the Efficacy of Therapeutic Interventions in Patients With Vasovagal Syncope: Results of a Controlled Study of Etilefrine Versus Placebo
More informationPositive Result in the Early Passive Phase of the Tilt-table Test: A Predictor of Neurocardiogenic Syncope in Young Men
ORIGINAL ARTICLE korean j intern med 202;27:60-65 pissn 226-3303 eissn 2005-6648 Positive Result in the Early Passive Phase of the Tilt-table Test: A Predictor of Neurocardiogenic Syncope in Young Men
More informationRandomized Placebo Controlled Trial of Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope. SPAIN Study.
Randomized Placebo Controlled Trial of Closed Loop Stimulation in Recurrent Reflex Vasovagal Syncope. SPAIN Study. Gonzalo Baron-Esquivias MD, PhD, FESC. Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC
More informationTilt training EM R1 송진우
Tilt training 2006.7.15. EM R1 송진우 Introduction North American Vasovagal Pacemaker Study Randomized, controlled trial Reduction in the likelihood of syncope by dual chamber pacing with rate drop response
More informationMalignant vasovagal syncope: a randomised trial of metoprolol and clonidine
268 Institute of Cardiology, Policlinico S Orsola, University of Bologna, Italy M Biffi G Boriani P Sabbatani G Bronzetti L Frabetti R Zannoli A Branzi B Magnani Correspondence to: Dr M Biffi, Institute
More informationThe effect of atropine in vasovagal syncope induced by head-up tilt testing
European Heart Journal (1999) 20, 1745 1751 Article No. euhj.1999.1697, available online at http://www.idealibrary.com on The effect of atropine in vasovagal syncope induced by head-up tilt testing M.
More informationRepeated tilt testing in patients with tilt-positive neurally mediated syncope
Europace (25) 7, 628e633 Repeated tilt testing in patients with tilt-positive neurally mediated syncope Hugo Ector a, *, Rik Willems a, Hein Heidbüchel a, Tony Reybrouck b,c a Department of Cardiology,
More informationFluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study
Europace (2006) 8, 193 198 doi:10.1093/europace/euj041 Fluoxetine vs. propranolol in the treatment of vasovagal syncope: a prospective, randomized, placebo-controlled study George N. Theodorakis*, Dionyssios
More informationORIGINAL ARTICLE. Tilt training and pacing: a report on 9 patients with neurally mediated syncope
Acta Cardiol 2010; 65(1): 3-7 doi: 10.2143/AC.65.1.2045882 3 ORIGINAL ARTICLE Tilt training and pacing: a report on 9 patients with neurally mediated syncope Tony REYBROUCK, PhD; Hein HEIDBÜCHEL, MD, PhD;
More informationTilt-table testing of patients with pacemaker and recurrent syncope Nielsen, Christian E. Haarmark; Kanters, Jørgen K.
university of copenhagen Tilt-table testing of patients with pacemaker and recurrent syncope Nielsen, Christian E. Haarmark; Kanters, Jørgen K.; Mehlsen, Jesper Published in: Indian Pacing and Electrophysiology
More informationRecurrent neurocardiogenic syncope, Tilt training program
Tilt Training for Recurrent Neurocardiogenic Syncope Effectiveness, Patient Compliance, and Scheduling the Frequency of Training Sessions Ozan KINAY, 1 MD, Mehmet YAZICI, 3 MD, Cem NAZLI, 1 MD, Gurkan
More informationSincopi ricorrenti: diagnosi differenziale e management. Alessandro Proclemer SOC Cardiologia Az. Osp.-Univ. Udine
Sincopi ricorrenti: diagnosi differenziale e management Alessandro Proclemer SOC Cardiologia Az. Osp.-Univ. Udine DISCLOSURE INFORMATION Dr. Alessandro Proclemer negli ultimi due anni ho avuto i seguenti
More informationIntroduction. * Corresponding author. Tel: þ ; fax: þ address:
Europace (2007) 9, 305 311 doi:10.1093/europace/eum017 Analysis of rhythm variation during spontaneous cardioinhibitory neurally-mediated syncope. Implications for RDR pacing optimization: an ISSUE 2 substudy
More informationImplications of mechanism of bradycardia on response to pacing in patients with unexplained syncope
Europace (2007) 9, 312 318 doi:10.1093/europace/eum020 Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope Sachin Sud, George J. Klein, Allan C. Skanes,
More informationElectrocardiographic characteristics of atrioventricular block induced by tilt testing
Europace (2009) 11, 225 230 doi:10.1093/europace/eun299 CLINICAL RESEARCH Syncope Electrocardiographic characteristics of atrioventricular block induced by tilt testing Dorota Zyśko 1 *, Jacek Gajek 2,
More informationSyncope: Causes and Treatment
March 01, 2006 By Avery Hayes, MD [1] and Mahendr S. Kochar, MD, MS [2] Because the causes of syncope are numerous and the diagnostic tests have low yield, this disorder is often difficult to evaluate.
More informationThe effect of education in preventing. recurrent vasovagal syncope
The effect of education in preventing recurrent vasovagal syncope Jin Ho Kim Department of Medicine The Graduate School, Yonsei University The effect of education in preventing recurrent vasovagal syncope
More informationDECLARATION OF CONFLICT OF INTEREST
DECLARATION OF CONFLICT OF INTEREST The Management of Syncope remains a challenge: Clues from the History Richard Sutton, DSc Emeritus Professor of Cardiology Imperial College, St Mary s Hospital, London,
More informationVariable Cerebral Dysfunction During Tilt Induced Vasovagal Syncope
Variable Cerebral Dysfunction During Tilt Induced Vasovagal Syncope FABRIZIO AMMIRATI, FURIO COLIVICCHI, GIANCARLO DI BATTISTA,* FAUSTO FIUME GARELLI,* GLAUDIO PANDOZI, and MASSIMO SANTINI From the *Heart
More informationKey Words: Head-up tilt test, Neurally mediated syncope, Unexplained syncope
203 Original Article Randomized Prospective Comparison of Two Protocols for Head-up Tilt Testing in Patients with Normal Heart and Recurrent Unexplained Syncope Mohammad Alasti, MD 1, Mohammad Hosein Nikoo,
More informationSyncope: Evaluation of the Weak and Dizzy
Syncope: Evaluation of the Weak and Dizzy William M. Miles, MD, FACC, FHRS Professor of Medicine Silverstein Chair for Cardiovascular Education University of Florida College of Medicine Disclosures Medtronic,
More informationTilt Table Testing MM /01/2015. HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service: Office, Outpatient
Tilt Table Testing Policy Number: Original Effective Date: MM.02.024 01/01/2015 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 09/22/2017 Section: Medicine Place(s) of Service:
More informationReview Article Tilt Table Test: State of The Art
www.ipej.org 239 Review Article Tilt Table Test: State of The Art Gonzalo Barón-Esquivias* MD, PhD, Antoni Martínez-Rubio** MD, FESC, FACC. *Cardiology Department, Hospital Universitario Virgen del Rocío.
More informationDeath after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013
Death after Syncope: Can we predict it? Daniel Zamarripa, MD Senior Medical Director December 2013 Death after Syncope: Can we predict it? Those who suffer from frequent and severe fainting often die suddenly
More informationSyncope: Evaluation of the Weak and Dizzy
Syncope: Evaluation of the Weak and Dizzy William M. Miles, MD, FACC, FHRS Professor of Medicine Silverstein Chair for Cardiovascular Education University of Florida College of Medicine Disclosures Medtronic,
More information13/09/2018. The ISSUE Studies. International (Italy & Spain) Study of Syncope of Uncertain Etiology. ISSUE study Pre-defined inclusion cathegories
The Studies Jean-Claude Deharo Aix-Marseille Université, France In Cardiac Electrophysiology Methods and Models Editors: Daniel C. Sigg, Paul A. Iaizzo, Yong-Fu Xiao, Bin He Springer 2010 study Pre-defined
More informationNeurocardiogenic Syncope
Do Now: 1. Have you ever fainted? Describe the experience. (If not, describe a time when you witnessed someone else faint.) 2. List and explain possible causes fainting. POWER P O W E R 10 points From
More informationVasovagal syncope represents a common disorder of the
Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope A Multicenter, Randomized, Controlled Trial Fabrizio Ammirati, MD; Furio Colivicchi, MD; Massimo Santini,
More informationGender Difference in Patients with Recurrent Neurally Mediated Syncope
Original Article DOI 10.3349/ymj.2010.51.4.499 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 51(4):499-503, 2010 Gender Difference in Patients with Recurrent Neurally Mediated Syncope Jungwae Park, 1
More informationas the cause of recurrent syncope 3 allows appropriate management aimed
Case Report Hellenic J Cardiol 2009; 50: 155-159 The Role of the Implantable Loop Recorder in the Investigation of Recurrent Syncope SKEVOS K. SIDERIS 1, TERESA A. MOUSIAMA 1, PAVLOS N. STOUGIANNOS 1,
More informationImplantable loop recorders Michele Brignole Arrhythmologic Center, Lavagna, Italy
Implantable loop recorders Michele Brignole Arrhythmologic Center, Lavagna, Italy DECLARATION OF CONFLICT OF INTEREST Medtronic, minimal ILR: available devices Reveal DX/XT, Medtronic Confirm, St Jude
More informationIl massaggio del seno carotideo Roberto Maggi Centro Aritmologico e Syncope Unit Lavagna, Italia
Il massaggio del seno carotideo Roberto Maggi Centro Aritmologico e Syncope Unit Lavagna, Italia Tigullio Cardiologia, 7 aprile 2016 Carotid sinus hypersensitivity Vagus nerve Glossopharyngeal nerve Carotid
More informationTilt-table test: its role in modern practice
CLINICAL PRACTICE Clinical Medicine 2013, Vol 13, No 3: 227 32 Tilt-table test: its role in modern practice Kulwinder S Sandhu, Pervez Khan, John Panting and Sunil Nadar ABSTRACT Syncope is a major healthcare
More information2018 ESC Guidelines for the diagnosis and management of syncope
2018 ESC Guidelines for the diagnosis and management of syncope Michele Brignole (Chairperson) (Italy); Angel Moya (Co-chairperson) (Spain); Jean-Claude Deharo (France); Frederik de Lange (The Netherlands);
More informationArrhythmia/Electrophysiology
Arrhythmia/Electrophysiology Pacemaker Therapy in Patients With Neurally Mediated Syncope and Documented Asystole Third International Study on Syncope of Uncertain Etiology (ISSUE-3) A Randomized Trial
More informationHeart Rate Variability Analysis Before and After Pacemaker Implantation in Neuromediated Syncopal Patients
148 April 2001 Heart Rate Variability Analysis Before and After Pacemaker Implantation in Neuromediated Syncopal Patients F. ZOLEZZI, C. ORVIENI, R. NEGRO, C.A. MAZZINI Division of Cardiology, Ospedale
More informationLONG-TERM FOLLOW-UP OF DDDR CLOSED-LOOP PACING FOR RECURRENT VASO-VAGAL SYNCOPE
LONG-TERM FOLLOW-UP OF DDDR CLOSED-LOOP PACING FOR RECURRENT VASO-VAGAL SYNCOPE M. Bortnik, G. Dell'era, E. Occhetta, L. Plebani, P. Marino University of Eastern Piedmont, Department of Cardiology, Novara,
More informationJune 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE
June 8, 2018, London UK TREATMENT OF VASOVAGAL SYNCOPE Where to go for help Syncope: HRS Definition Syncope is defined as: a transient loss of consciousness, associated with an inability to maintain postural
More information134 Adrian Baranchuk, MD FACC 1, William McIntyre BSc MD 1, William Harper, MD 2, Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC 2.
www.ipej.org 134 Original Article Application Of The American College Of Emergency Physicians (ACEP) Recommendations And a Risk Stratification Score (OESIL) For Patients With Syncope Admitted From The
More informationJournal of the American College of Cardiology Vol. 40, No. 3, by the American College of Cardiology Foundation ISSN /02/$22.
Journal of the American College of Cardiology Vol. 40, No. 3, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01974-5
More informationDiagnostic and therapeutic management of the patient with syncope M. Brignole Arrhythmologic Centre and Syncope Unit Lavagna, Italy
Diagnostic and therapeutic management of the patient with syncope M. Brignole Arrhythmologic Centre and Syncope Unit Lavagna, Italy Eur Heart J. 2009 Nov;30(21):2631-71 Available on www.escardio.org/guidelines
More informationThe Newcastle protocols for head-up tilt table testing in the diagnosis of vasovagal syncope, carotid sinus hypersensitivity, and related disorders
564 Heart 2000;83:564 569 PRACTICE OBSERVED Cardiovascular Investigation Unit, Victoria Wing, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK R A Kenny D O Shea SWParry Correspondence
More informationOver the past decade, tilt testing has become a widely
Induction of Neurally Mediated Syncope With Adenosine Suneet Mittal, MD; Kenneth M. Stein, MD; Steven M. Markowitz, MD; David J. Slotwiner, MD; Sameer Rohatgi, MD; Bruce B. Lerman, MD Background Tilt testing
More informationA COST-UTILITY ANALYSIS OF PACEMAKERS FOR THE TREATMENT OF NEURALLY MEDIATED SYNCOPE
A COST-UTILITY ANALYSIS OF PACEMAKERS FOR THE TREATMENT OF NEURALLY MEDIATED SYNCOPE Craig R. Mitton 1, M. Sarah Rose 1, Robert S. Sheldon 2 Working Paper 98-5 1 Department of Community Health Sciences,
More informationManagement of syncope in 2014 Role of tilt test
Gdansk BEATA Symposium October 10-11, 2014 Management of syncope in 2014 Role of tilt test Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation, Mestre Venice, Italy Protocols /
More informationResearch Article Recurrent Syncope in Patients with Carotid Sinus Hypersensitivity
International Scholarly Research Network ISRN Cardiology Volume 2012, Article ID 216206, 5 pages doi:10.5402/2012/216206 Research Article Recurrent Syncope in Patients with Carotid Sinus Hypersensitivity
More informationVasovagal syncope in 2016: the current state of the faint
Interventional Cardiology Vasovagal syncope in 2016: the current state of the faint In this article, we will review the challenges in defining syncope and the evolution of its definition over the past
More informationEffectiveness of Physical Counterpressure Maneuvers in Preventing Vasovagal Syncope The Physical Counterpressure Manoeuvres Trial (PC-Trial)
Journal of the American College of Cardiology Vol. 48, No. 8, 2006 2006 by the American College of Cardiology Foundation ISSN 0735-1097/06/$32.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2006.06.059
More informationSyncope Guidelines: What s New?
Syncope Guidelines: What s New? Dr. Samuel Asirvatham Professor of Medicine and Pediatrics Mayo Clinic College of Medicine Medical Director, Electrophysiology Laboratory Program Director, EP Fellowship
More informationTiming of First Recurrence of Syncope Predicts Syncopal Frequency After a Positive Tilt Table Test Result
1284 JACC Vol. 29, No. 6 SYNCOPE Timing of First Recurrence of Syncope Predicts Syncopal Frequency After a Positive Tilt Table Test Result PAUL MALIK, MD, MARY LOU KOSHMAN, RN, ROBERT SHELDON, MD, PHD
More informationPermanent pacing for cardioinhibitory malignant
274 Chelsea and Westminster Hospital, London M V Petersen R Chamberlain-Webber A P Fitzpatrick A Ingram T Williams R Sutton Correspondence to: Dr Richard Sutton, Department of Cardiology, Chelsea and Westminster
More informationΣε όλους τους ασθενείς με σύνδρομο ευερέθιστου καρωτιδικού κόλπου και συγκοπή πρέπει να εμφυτεύεται μόνιμος βηματοδότης Κατά
Σε όλους τους ασθενείς με σύνδρομο ευερέθιστου καρωτιδικού κόλπου και συγκοπή πρέπει να εμφυτεύεται μόνιμος βηματοδότης Κατά Δρ. H.Θ. Ζάρβαλης Καρδιολογική Κλινική Γ.Ν. Παπαγεωργίου Θεσσαλονίκη Classification
More informationTilt Table Testing and Implantable Loop Recorders for Syncope
Tilt Table Testing and Implantable Loop Recorders for Syncope Robert Sheldon, MD, PhD KEYWORDS Tilt table tests Implantable loop recorders Syncope Randomized studies Diagnosis KEY POINTS Tilt table tests
More informationSyncope Guidelines Update. Bernard Harbieh, FHRS AUBMC-KMC Beirut-Lebanon
Syncope Guidelines Update Bernard Harbieh, FHRS AUBMC-KMC Beirut-Lebanon New Syncope Guidelines Increase the volume of information on diagnosis and management Incorporation of emergency specialists, neurologists,
More informationRole of Implantable Loop Recorder in the Evaluation of Syncope
Role of Implantable Loop Recorder in the Evaluation of Syncope June Soo Kim, M.D., Ph.D. Department of Medicine Cardiac & Vascular Center Sungkyunkwan University School of Medicine Definition & Mechanism
More informationFront-loaded head-up tilt table testing: validation of a rapid first line nitrate-provoked tilt protocol for the diagnosis of vasovagal syncope
Age and Ageing 2008; 37: 411 415 doi:10.1093/ageing/afn098 The Author 2008. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For Permissions, please
More informationIndex. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Adenosine in idiopathic AV block, 445 446 Adolescent(s) syncope in, 397 409. See also Syncope, in children and adolescents AECG monitoring.
More informationEffectiveness of Fludrocortisone and Salt in Preventing Syncope Recurrence in Children A Double-Blind, Placebo-Controlled, Randomized Trial
Journal of the American College of Cardiology Vol. 45, No. 4, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.11.033
More information2018 ESC SYNCOPE GUIDELINES SUMMARY
208 ESC SYNCOPE GUIDELINES SUMMARY NEW GUIDELINES OVERVIEW OF UPDATED RECOMMENDATIONS SINCE 2009 208 EUROPEAN SOCIETY OF CARDIOLOGY SYNCOPE GUIDELINES Goals of 208 Task Force Reducing Cost & Admissions:
More informationClinical features of adenosine sensitive syncope and tilt induced vasovagal syncope
24 Arrhythmologic Centre, Ospedali Riuniti, Lavagna, Italy M Brignole G Gaggioli S Costa A Bartoletti Arrhythmologic Centre, Ospedale S Maria Nuova, Reggio Emilia, Italy C Menozzi N Bottoni G Lolli Department
More informationOBJECTIVES BACKGROUND METHODS
Journal of the American College of Cardiology Vol. 34, No. 5, 1999 1999 by the American College of Cardiology ISSN 0735-1097/99/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00365-4 Diagnostic
More informationNational Coverage Determination (NCD) for Cardiac Pacemakers (20.8)
Page 1 of 12 Centers for Medicare & Medicaid Services National Coverage Determination (NCD) for Cardiac Pacemakers (20.8) Tracking Information Publication Number 100-3 Manual Section Number 20.8 Manual
More information16033 Lavagna, Italy b Interventional Cardiology Unit, Department of Cardiology, Azienda Ospedaliera Santa Maria
Europace (2005) 7, 273e279 The usage and diagnostic yield of the implantable loop-recorder in detection of the mechanism of syncope and in guiding effective antiarrhythmic therapy in older people Michele
More informationLee Chee Wan. Senior Consultant Pacing and Cardiac Electrophysiology. GP Symposium 2 nd April 2016
Lee Chee Wan Senior Consultant Pacing and Cardiac Electrophysiology GP Symposium 2 nd April 2016 Objectives Definition of syncope Common causes of syncope & impacts How to clinically assess patient with
More informationEVALUATION OF SYNCOPE
Indep Rev Oct-Dec 2013;15(10-12) IR-264 EVALUATION OF SYNCOPE Muhammad Sarfraz Key Contents Concept of syncope Diagnostic work-up of syncope Test for causes of syncope Investigation of syncope Learning
More informationNeurocardiogenic syncope
Neurocardiogenic syncope Syncope Definition Collapse,Blackout A sudden, transient loss of consciousness and postural tone, with spontaneous recovery Very common Syncope Prevalence All age groups (particularly
More informationVariations in diagnostic yield of head-up tilt test and electrophysiology in groups of patients with syncope of unknown origin
European Heart Journal (2001) 22, 857 865 doi:10.1053/euhj.2000.2398, available online at http://www.idealibrary.com on Variations in diagnostic yield of head-up tilt test and electrophysiology in groups
More informationShock Reduction Strategies Michael Geist E. Wolfson MC
Shock Reduction Strategies Michael Geist E. Wolfson MC Shock Therapy Thanks, I needed that! Why Do We Need To Reduce Shocks Long-term outcome after ICD and CRT implantation and influence of remote device
More informationClinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof of Cardiology, University Hospital of Crete
Clinical Case 1 A patient with a syncope Panos E. Vardas President Elect of the ESC, Prof. of Cardiology, University Hospital of Crete Case presentation A 64-year-old male smoker, with arterial hypertension
More informationThe relevance of a junctional rhythm during neurocardiogenic reaction provoked by tilt testing
The relevance of a junctional rhythm during neurocardiogenic reaction provoked by tilt testing Dorota Zyśko, Jacek Gajek Wroclaw Medical University, Wroclaw, Poland ESC STOCKHOLM 2010 Junctional rhythm
More informationMedical Management of Vasovagal Syncope: A Network Meta Analysis
Research Article Medical Management of Vasovagal Syncope: A Network Meta Analysis Rohit S. Loomba 1*, Karan Nijhawan 2, Saurabh Aggarwal 3, Rohit R. Arora 4 1 Children s Hospital of Wisconsin/Medical College
More informationRemote Monitoring & the Smart Home of the 21 Century
Cardiostim EHRA Europace 2016, Nice - June 8-11, 2016 Remote Monitoring & the Smart Home of the 21 Century Antonio Raviele, MD, FESC, FHRS President ALFA -Alliance to Fight Atrial fibrillation- Venezia
More informationThe relationship between carotid sinus hypersensitivity, orthostatic hypotension, and vasovagal syncope: a case control study
Europace (2008) 10, 1400 1405 doi:10.1093/europace/eun278 The relationship between carotid sinus hypersensitivity, orthostatic hypotension, and vasovagal syncope: a case control study Maw Pin Tan 1,2,
More informationThe relationship between carotid sinus hypersensitivity, orthostatic hypotension, and vasovagal syncope: a case control study
Europace (2008) 10, 1400 1405 doi:10.1093/europace/eun278 The relationship between carotid sinus hypersensitivity, orthostatic hypotension, and vasovagal syncope: a case control study Maw Pin Tan 1,2,
More informationTilt Table Testing. Dr. Prateek Suri
Tilt Table Testing Dr. Prateek Suri Background Syncope is very commonly seen in the population Among the various causes of syncope vasovagal syncope is the most common cause There is an absence of a gold
More informationExercise-related syncope in young competitive athletes without evidence of structural heart disease
European Heart Journal (2002) 23, 1125 1130 doi:10.1053/euhj.2001.3042, available online at http://www.idealibrary.com on Exercise-related syncope in young competitive athletes without evidence of structural
More informationReview Article Evaluation of Syncope: An Overview
www.ipej.org 12 Review Article Evaluation of Syncope: An Overview Anoop Kumar Gupta, MD, DM; Alok Maheshwari, MD; Yash Lokhandwala MD,DM. Michigan State University, Lansing, MI, USA. Address for Correspondence:
More informationManagement of Syncope in Heart Failure. University of Iowa
Management of Syncope in Heart Failure Brian Olshansky University of Iowa 1 Syncope Transient loss of consciousness, with rapid, usually complete, recovery, with or without prodrome A common, non-specific,
More informationCan prodromal symptoms predict recurrence of vasovagal syncope?
ORIGINAL ARTICLE Cardiology Journal 2008, Vol. 15, No. 5, pp. 446 450 Copyright 2008 Via Medica ISSN 1897 5593 Can prodromal symptoms predict recurrence of vasovagal syncope? Amir Farjam Fazelifar 1, Hosein
More informationFrith J, Parry SW. Tilt-table testing: down but not out. Clinical Practice 2014, 11(3),
Frith J, Parry SW. Tilt-table testing: down but not out. Clinical Practice 2014, 11(3), 265-268. Copyright: 2014 Future Medicine Ltd. DOI link to article: http://dx.doi.org/10.2217/cpr.14.21 Date deposited:
More informationThe normal response to prolonged passive head up tilt testing
Heart 2000;84:509 514 509 Department of Cardiology, Chelsea and Westminster Hospital, 369 Fulham Road, London SW10 9NH, UK MEVPetersen T R Williams C Gordon R Chamberlain-Webber R Sutton Correspondence
More informationImproving Patient Outcomes with a Syncope Center. Suneet Mittal, MD
Improving Patient Outcomes with a Syncope Center Suneet Mittal, MD Improving Patient Outcomes with a Syncope Center: Early Risk Stratification of Patients who Require Device Therapy Suneet Mittal, MD Director,
More informationSyncope evaluation: the role of syncope clinics Michele Brignole Arrhythmologic Centre, Lavagna, Italy
Syncope evaluation: the role of syncope clinics Michele Brignole Arrhythmologic Centre, Lavagna, Italy Why should we need a Syncope Management Unit? We are not happy with current strategies: - not standardized
More informationThe randomized, double-blind, Third International Study. Original Article
Original Article Benefit of Pacemaker Therapy in Patients With Presumed Neurally Mediated Syncope and Documented Asystole Is Greater When Tilt Test Is Negative An Analysis From the Third International
More informationThe benefit of a remotely monitored implantable loop recorder as a first line investigation in unexplained syncope: the EaSyAS II trial
Europace (216) 18, 912 918 doi:1.193/europace/euv228 CLINICAL RESEARCH Electrocardiology and risk stratification The benefit of a remotely monitored implantable loop recorder as a first line investigation
More informationRapid Access Clinics for Transient Loss of Consciousness
Rapid Access Clinics for Transient Loss of Consciousness Michael Gammage Department of Cardiovascular Medicine University of Birmingham and University Hospital Birmingham NHS Foundation Trust Those who
More informationSyncope. Peter Netzler AnMed Health Arrhythmia Specialists February 22, 2014
Syncope Peter Netzler AnMed Health Arrhythmia Specialists February 22, 2014 Syncope I have no disclosures 1. Incidence and prevalence 2. Broad differential 3. Risk Stratification 4. Work up and treatment
More informationSyncope By Remus Popa
Syncope By Remus Popa A 66 years old male is brought to the ED from a restaurant where he fainted while dining out with his family. He complained of nausea and stood up to go to the restroom but immediately
More informationSyncope Due to Idiopathic Paroxysmal Atrioventricular Block
Journal of the American College of Cardiology Vol. 58, No. 2, 2011 2011 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2010.12.045
More informationDecember D. EL ALLAF Centre Hospitalier Hutois, Huy, Belgium. P. ATTUEL Centre Chirurgical Val d'or, Saint Cloud, France
December 2000 449 European Multicenter Study on the Prevention of Paroxysmal Atrial Fibrillation by Permanent Overdrive Pacing: Atrial Rate Behavior and Patient Tolerance D. EL ALLAF Centre Hospitalier
More informationTLOC - What are the red flags? John Dean March 2018
TLOC - What are the red flags? John Dean March 2018 What is TLOC? Transient loss of consciousness It is very common It accounts for 5% of ED attendances It accounts for 6% of hospital admissions It consumes
More informationValue of the implantable loop recorder for the management of patients with unexplained syncope
Europace (2004) 6, 70e76 Value of the implantable loop recorder for the management of patients with unexplained syncope Lucas Boersma a, ), Lluís Mont b, Alessandro Sionis b, Emilio García b, Josep Brugada
More informationSincope e bradicardia sinusale: quale è la terapia appropriata?
Sincope e bradicardia sinusale: quale è la terapia appropriata? Paolo Alboni, Key points: 1 Fisiopatologia della sincope nei pz con BS 2 Diagnosi del tipo of sincope nei pz con BS 3 Trattamento della syncope
More information